Blackstone agrees to invest up to $750m in Moderna’s flu program; Wellspring closing nearly $1bn multi-asset continuation fund
SKKY Partners' David Brisske talks about joining the firm, its first deal; Blackstone Life Sciences agrees to fund up to $750m in Moderna's flu program; Wellspring to close nearly $1bn multi-asset continuation fund.
27 March 2024•4 mins read
